| Trial ID: | L5816 |
| Source ID: | NCT00654056
|
| Associated Drug: |
Actrapid (Human Insulin)
|
| Title: |
Severe Insulin Resistance in Patients With Type 2 Diabetes
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type 2 Diabetes Mellitus
|
| Interventions: |
DRUG: Actrapid (human insulin)
|
| Outcome Measures: |
Primary: Insulin sensitivity, 8 hours | Secondary: Changes in insulin signaling proteins?, 1 month
|
| Sponsor/Collaborators: |
Sponsor: University of Aarhus | Collaborators: Aarhus University Hospital|Regionshospitalet Silkeborg
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
|
| Enrollment: |
8
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: SINGLE (PARTICIPANT)|Primary Purpose: BASIC_SCIENCE
|
| Start Date: |
2008-03
|
| Completion Date: |
2009-10
|
| Results First Posted: |
|
| Last Update Posted: |
2013-03-11
|
| Locations: |
|
| URL: |
https://clinicaltrials.gov/show/NCT00654056
|
